<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal differentiation and maturation of hemopoietic cells are characteristic features of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Tryptases (alpha- and beta-type) are lineage-restricted serine proteases primarily expressed in mast cells (MC) </plain></SENT>
<SENT sid="2" pm="."><plain>We have analyzed expression of tryptase in 89 de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), n = 30; RA with ringed sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), n = 21; RA with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), n = 27; <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>), n = 11) </plain></SENT>
<SENT sid="3" pm="."><plain>Serum levels of total tryptase (alpha - protryptase + beta - tryptase) were measured by FIA </plain></SENT>
<SENT sid="4" pm="."><plain>The numbers of tryptase+ cells were determined in paraffin-embedded bone marrow (bm) sections by immunohistochemistry and morphometry </plain></SENT>
<SENT sid="5" pm="."><plain>In healthy individuals, serum total tryptase levels ranged between &lt; 1 and 15 ng/ml (5.6 +/- 2.8 ng/ml) </plain></SENT>
<SENT sid="6" pm="."><plain>Tryptase levels of &gt; 20 ng/ml were detected in 5/22 patients with RA (22.7%), 4/17 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (23.5%), 0/16 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t, and 3/8 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> (37.5%) </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, serum tryptase concentrations were higher in RA (16.6 +/- 14.3 ng/ml), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (12.9 +/- 8.2), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> (16.5 +/- 7.6) compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/-t (8.7 +/- 3.8) </plain></SENT>
<SENT sid="8" pm="."><plain>By morphometry, elevated numbers of tryptase+ bm cells were detected in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> groups (RA: 139 +/- 131; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>: 118 +/- 98; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t: 80 +/- 79; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>: 105 +/- 114 cells/mm2) compared to controls (54 +/- 51 cells/mm2) </plain></SENT>
<SENT sid="9" pm="."><plain>As assessed by Northern blotting and protein analysis, bm cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> primarily produced alpha-(pro)tryptase, but little or no beta-tryptase </plain></SENT>
<SENT sid="10" pm="."><plain>Together, our data show that elevated levels of tryptase are detectable in a group of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> probably because of an increase in neoplastic (mast) cells producing the enzyme(s) </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, serum tryptase levels appear to correlate with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> variants </plain></SENT>
<SENT sid="12" pm="."><plain>Follow up studies should clarify whether an elevated tryptase concentration in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is of prognostic significance </plain></SENT>
</text></document>